Drug Price Trends for ALBUTEROL SULF

Average Pharmacy Cost for ALBUTEROL SULF

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
ALBUTEROL SULF 2 MG/5 ML SYRUP	70752-0102-12	0.03773	ML	2024-12-18
ALBUTEROL SULF 2 MG/5 ML SYRUP	62135-0189-47	0.03773	ML	2024-12-18
ALBUTEROL SULFATE 4 MG TAB	75834-0274-01	0.32968	EACH	2024-12-18

Market Analysis and Price Projections for Albuterol Sulfate

Introduction to Albuterol Sulfate

Albuterol sulfate is a widely used bronchodilator, essential for treating or preventing bronchospasm in individuals with reversible obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is also effective in preventing exercise-induced bronchospasm. Available in various forms, including inhalation solutions, metered-dose inhalers, and dry powder inhalers, albuterol sulfate is a cornerstone in respiratory care.

Market Overview

The global albuterol sulfate market is segmented based on product type, application, end-use industry, and region. Here are some key aspects of the market:

Product Types

The market is sub-segmented into different concentrations of albuterol sulfate inhalation solutions, such as 0.083%, 0.042%, 0.021%, and 0.5% solutions[1].

End-Use Industry

The market is primarily divided into pediatrics and adults, with significant demand from both segments due to the prevalence of respiratory disorders across all age groups[1].

Regional Analysis

The demand for albuterol sulfate is high in North America, driven by the healthcare sector. In the Asia Pacific region, countries like China and India exhibit substantial demand due to their large and growing populations[1].

Market Drivers

Several factors are driving the growth of the albuterol sulfate market:

Rising Incidences of Respiratory Disorders

The increasing prevalence of asthma, COPD, and other respiratory diseases is a major driver. These conditions are exacerbated by factors such as air pollution and urbanization, leading to higher demand for albuterol sulfate[3].

Advancements in Inhalation Therapy

Technological advancements in inhaler technology, including metered-dose and dry powder inhalers, have expanded treatment options and improved patient compliance. Regulatory approvals for generic formulations also contribute to market growth[3].

Changing Lifestyles and Demographics

Adoption of sedentary lifestyles and an increase in the geriatric population further fuel the demand for albuterol sulfate. Patient education programs and healthcare reforms promoting respiratory health awareness also support market expansion[4].

Market Size and Projections

Current Market Size

As of 2023, the albuterol sulfate inhalation aerosol market was valued at USD 2.38 billion[3].

Future Projections

The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.1% from 2024 to 2031, reaching a projected value of USD 4.07 billion by 2031[3].

Price Analysis

The prices of albuterol sulfate vary based on the form and concentration of the medication, as well as the pharmacy.

Inhalation Solutions

• For a 2.5 mg/3 mL (0.083%) solution, prices range from $18.17 to $30.31 for 75 to 180 milliliters, respectively[5].
• For a 1.25 mg/3 mL (0.042%) solution, prices start from $22.78 for 75 milliliters[5].

Metered-Dose Inhalers

Prices for metered-dose inhalers can vary significantly depending on the brand and generic availability. For instance, generic versions can be more affordable, with prices starting from around $20-$40 for a standard dose[2].

Impact of Discounts and Coupons

Discounts and coupons can significantly reduce the cost of albuterol sulfate. For example, SingleCare coupons can lower the retail price from around $54 to $8.11 for a 25-unit pack of 2.5 mg/3 mL solution[2].

Competitive Landscape

The global albuterol sulfate market is competitive, with several key players:

Major Manufacturers

Companies like Teva, Mylan, Akorn, GSK, and Merck are prominent in the market. These companies invest heavily in research and development, contributing to market growth through innovative products and generic formulations[1][4].

Recent Developments

In May 2020, Lupin received FDA approval for its generic version of ProAir, an albuterol sulfate inhalation aerosol, which has further expanded the market[4].

Challenges and Restraints

While the market is growing, there are some challenges:

Side Effects

Albuterol sulfate can have side effects, which may restrain market growth. However, these are generally manageable and do not significantly deter demand[4].

Regulatory Environment

Changes in regulatory policies can impact the market. However, recent approvals for generic formulations have been positive for market expansion[3].

Key Takeaways

• Growing Demand: The albuterol sulfate market is driven by increasing respiratory disorders and advancements in inhalation therapy.
• Market Size: The market is projected to grow from USD 2.38 billion in 2023 to USD 4.07 billion by 2031.
• Price Variability: Prices vary based on form, concentration, and pharmacy, with discounts and coupons offering significant savings.
• Competitive Landscape: Major manufacturers like Teva, Mylan, and GSK dominate the market, with ongoing innovations and generic approvals.
• Challenges: Side effects and regulatory changes are potential restraints, but overall market growth is positive.

FAQs

Q: What is albuterol sulfate used for? A: Albuterol sulfate is used to treat or prevent bronchospasm in people with reversible obstructive airway diseases such as asthma and COPD, and to prevent exercise-induced bronchospasm.

Q: What are the different forms of albuterol sulfate available? A: Albuterol sulfate is available in various forms, including inhalation solutions, metered-dose inhalers, and dry powder inhalers.

Q: How is the albuterol sulfate market segmented? A: The market is segmented based on product type, application, end-use industry, and region.

Q: What are the key drivers of the albuterol sulfate market? A: Key drivers include rising incidences of respiratory disorders, advancements in inhalation therapy, and changing lifestyles and demographics.

Q: What is the projected growth rate of the albuterol sulfate market? A: The market is expected to grow at a CAGR of 7.1% from 2024 to 2031.

Sources

1. OpenPR: 2020-2025: Albuterol Sulfate Inhalation Solution Market Grow By Leading Industry Teva, Mylan and Akorn in the World.
2. SingleCare: Albuterol Sulfate Coupons & Prices.
3. Market Research Intellect: Albuterol Sulfate Inhalation Aerosol Market Size and Projections.
4. Allied Market Research: Salbutamol Sulfate Market Trends Analysis & Forecast By 2030.
5. Drugs.com: Albuterol Prices, Coupons, Copay Cards & Patient Assistance.